Skip to main content

Table 3 Mean signal intensities of various proteins and peptides comparing endometrium of women with a normal pelvis versus stage I-II endometriosis (CM10 and IMAC)

From: TRIzol treatment of secretory phase endometrium allows combined proteomic and mRNA microarray analysis of the same sample in women with and without endometriosis

CM10

    

SPAhigh

    

M/z

pvalue

Mean Disease

Mean Control

Up/down

8898,40

0,036

4,475

1,935

up

10115,90

0,036

8,002

3,545

up

11656,79

0,036

6,899

2,721

up

11861,80

0,008

3,013

1,160

up

12186,64

0,014

0,386

0,132

up

12379,95

0,008

1,580

0,420

up

12847,34

0,023

0,668

0,228

up

13464,70

0,036

0,432

0,198

up

14659,37

0,023

2,197

1,049

up

SPAlow

    

7662,79

0,036

0,190

0,362

down

8078,54

0,022

0,118

0,339

down

8949,82

0,008

1,326

0,720

up

9941,98

0,008

2,382

1,234

up

10084,76

0,022

1,900

1,096

up

11801,42

0,014

0,875

0,432

up

11835,69

0,008

0,507

0,284

up

12323,14

0,008

0,727

0,215

up

15199,86

0,014

0,010

0,088

down

IMAC

    

CHCA

    

M/z

pvalue

Mean Disease

Mean Control

Up/down

11163,87

0,022

0,469

0,245

up

11322,71

0,008

0,836

0,294

up

13815,44

0,014

3,281

1,411

up

15446,04

0,036

0,283

0,108

up

SPAlow

    

8228,62

0,014

0,429

0,198

up